How Insitro Is Using AI to Create Better Medicines: In Conversation With Daphne Koller
vitalsignshealth.substack.com
On our first crossover episode between Unsupervised Learning and Vital Signs, we dove deep into the world of using AI in drug development with Insitro CEO Daphne Koller. See the full episode below! We sat down with Daphne to discuss how Insitro distinguishes itself from other AI drug discovery companies, where ML can drive the most impact in drug development, if foundation models transform drug discovery and edtech, and more. You can listen to the full conversation on
How Insitro Is Using AI to Create Better Medicines: In Conversation With Daphne Koller
How Insitro Is Using AI to Create Better…
How Insitro Is Using AI to Create Better Medicines: In Conversation With Daphne Koller
On our first crossover episode between Unsupervised Learning and Vital Signs, we dove deep into the world of using AI in drug development with Insitro CEO Daphne Koller. See the full episode below! We sat down with Daphne to discuss how Insitro distinguishes itself from other AI drug discovery companies, where ML can drive the most impact in drug development, if foundation models transform drug discovery and edtech, and more. You can listen to the full conversation on